Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) (Q33401001)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

title

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

main subject

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

author

David P. Steensma

series ordinal

6

object named as

David P Steensma

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Guillermo Garcia-Manero

series ordinal

10

object named as

Guillermo Garcia-Manero

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

author name string

Azra Raza

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Naomi Galili

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Deborah Mulford

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Scott E Smith

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Gail L Brown

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Roger M Lyons

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Ralph Boccia

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Mikkael A Sekeres

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Ruben A Mesa

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

publication date

30 April 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

published in

Journal of Hematology & Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

page(s)

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

start time

30 April 2012

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

stated in

April 2022 Public Data File from Crossref

cites work

Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: a case report of sustained hematologic response following an abbreviated exposure

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Cytogenetics in acute leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

21 June 2018

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1756-8722-5-18

retrieved

21 January 2018

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

retrieved

31 October 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1756-8722-5-18

retrieved

21 January 2018

Identifiers

DOI

10.1186/1756-8722-5-18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

Dimensions Publication ID

1050452801

1 reference

stated in

SciGraph

reference URL

https://scigraph.springernature.com/pub.10.1186/1756-8722-5-18

retrieved

9 September 2019

PMC publication ID

3416694

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

PubMed publication ID

22546242

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22546242

retrieved

26 July 2017

ResearchGate publication ID

224869906

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33401001&oldid=2195324944"